Skadden has advised Otsuka Pharmaceutical Co., Ltd. Kirkland & Ellis has advised Transcend Therapeutics, Inc. Otsuka Pharmaceutical Co., Ltd., through its wholly owned subsidiary Otsuka America,...
Otsuka Pharmaceutical to Acquire Transcend Therapeutics in $1.225 Billion Transaction
Otsuka Pharmaceutical’s Acquisition of Jnana Therapeutics
Skadden is advising Otsuka, while Latham & Watkins is advising Jnana on the deal. Nutraceutical and pharmaceutical company Otsuka Holdings Co. Ltd., (Otsuka), announced the definitive...
Otsuka’s Acquisition of Konica Minolta’s Biomarker Measurement Technology
Jones Day advised Otsuka Pharmaceutical Co. on the deal. Otsuka Pharmaceutical Co., Ltd. has signed a contract with Konica Minolta Co., Ltd to acquire Konica Minolta’s new...
Sunovion Pharmaceuticals’ Co-Development and Co-Commercialization Agreement with Otsuka Pharmaceutical
Ropes & Gray advised Sunovion Pharmaceuticals on the deal while Cooley represented Otsuka Pharmaceutical. Sunovion Pharmaceuticals Inc., a subsidiary of Japan’s Sumitomo Dainippon Pharma, signed a...